sur Right Seasons Investments (CVE:LITT)
FutureGen Industries Reports Investment Gains and Portfolio Updates
FutureGen Industries Corp., a firm operating on the TSX Venture Exchange, shared notable gains from its strategic portfolio decisions, reflecting its investment approach. The company detailed its recent activities with Onco-Innovations, ASEP Medical Holdings, and Core One Labs.
In June 2025, FutureGen invested $31,175 in Onco-Innovations Limited, later selling shares for gains of $765,065.33. Onco-Innovations is known for advancing cancer treatment technologies, focusing on PNKP-inhibitor therapies.
Regarding ASEP Medical Holdings, FutureGen's initial investment in Safecoat Medical transformed after ASEP's acquisition. Selling ASEP shares yielded $118,255.57. ASEP focuses on sepsis diagnostics and biofilm infection therapies.
FutureGen's investment in Core One Labs converted into shares following a merger, generating a gain of $167,473.19. Core One advances psychedelic medicines for mental health treatments.
FutureGen's CEO, Kristian Thorlund, emphasized their commitment to disciplined capital deployment to enhance shareholder value.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Right Seasons Investments